NBE Therapeutics

1 follower


NBE-Therapeutics is developing best-in-class cancer therapies to increase survival and improve quality of life for cancer patients worldwide. The company’s next-generation immune-stimulatory therapies are based on a proprietary, highly differentiated Antibody-Drug Conjugate (ADC) platform. This best... Read more

Industries

Headquarters

Basel, Switzerland

Employees

11-50

Links

Org chart

Jean Engela

Collapse
Gerd Munzert
Chief Clinical Officer
Carl Deutsch, PhD, MBA
Chief Scientific Officer
Cornelia Baumgartner- Diolaiuti
Consulting Clinical Operations Manager
Giuliano Bellapadrona
Associate Director, Global CMC
Hüseyin Birogul
Head of Conjugation
Ina Hellmann
Program Manager Early Development
Marco Meier
Head of in vivo unit
Mariarosa Spina Horn
Human Resources Business Partner
Ulrike Fiedler
Senior Director Program Management and Pipeline Innovation
Florian Durante
Financial Controller
Andrea Brychcy
Research Assistant
Manuel Biehler
Research Assistant
Yannick L. Fischer
Research Associate II
Valentina Mele
Lab Manager
Rémy Gébleux
Senior Scientist
Rachel Plonka
Research Associate
Nina Alder
Research Assistant II
Melanie R.
Research Associate
Julie Fierle
Scientist
Antoine Kraemer
Research Associate
Alexandra Musch
Research associate
Jenny Böhme
Research Associate I
Saskia Schätz
Research Associate
Lukas Bammert
Research Scientist
Sophia Conwell
Research Associate I
Timo Lüthi
Research Assistant I